Logo image of PEN

PENUMBRA INC (PEN) Stock Overview

USA - NYSE:PEN - US70975L1070 - Common Stock

253.37 USD
+4.17 (+1.67%)
Last: 9/26/2025, 8:22:24 PM
253.37 USD
0 (0%)
After Hours: 9/26/2025, 8:22:24 PM

PEN Key Statistics, Chart & Performance

Key Statistics
52 Week High310
52 Week Low186.97
Market Cap9.88B
Shares39.00M
Float37.54M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)3.51
PE72.19
Fwd PE49.82
Earnings (Next)10-28 2025-10-28/amc
IPO09-18 2015-09-18
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


PEN short term performance overview.The bars show the price performance of PEN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6

PEN long term performance overview.The bars show the price performance of PEN in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of PEN is 253.37 USD. In the past month the price decreased by -6.74%. In the past year, price increased by 32.27%.

PENUMBRA INC / PEN Daily stock chart

PEN Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.26 232.44B
ISRG INTUITIVE SURGICAL INC 54.8 158.13B
BSX BOSTON SCIENTIFIC CORP 34.69 145.48B
SYK STRYKER CORP 28.72 141.08B
MDT MEDTRONIC PLC 17.04 120.86B
BDX BECTON DICKINSON AND CO 12.94 52.91B
IDXX IDEXX LABORATORIES INC 52.64 50.58B
EW EDWARDS LIFESCIENCES CORP 29.67 44.77B
RMD RESMED INC 28.3 39.57B
GEHC GE HEALTHCARE TECHNOLOGY 15.55 33.08B
DXCM DEXCOM INC 39.47 26.31B
PHG KONINKLIJKE PHILIPS NVR- NY 15.87 25.83B

About PEN

Company Profile

PEN logo image Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. The company is headquartered in Alameda, California and currently employs 4,500 full-time employees. The company went IPO on 2015-09-18. The firm's broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe. The company focuses on developing, manufacturing and marketing novel products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. Some of the conditions it focuses on are Pulmonary Embolism, Deep Vein Thrombosis, Acute Limb Ischemia, Ischemic Stroke, Acute Coronary Syndrome, and Clot associated with Arteriovenous Graft or Fistula. The firm sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Company Info

PENUMBRA INC

One Penumbra Place

Alameda CALIFORNIA 94502 US

CEO: Adam Elsesser

Employees: 4500

PEN Company Website

PEN Investor Relations

Phone: 15109952486

PENUMBRA INC / PEN FAQ

What is the stock price of PENUMBRA INC today?

The current stock price of PEN is 253.37 USD. The price increased by 1.67% in the last trading session.


What is the ticker symbol for PENUMBRA INC stock?

The exchange symbol of PENUMBRA INC is PEN and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is PEN stock listed?

PEN stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for PENUMBRA INC stock?

23 analysts have analysed PEN and the average price target is 318.84 USD. This implies a price increase of 25.84% is expected in the next year compared to the current price of 253.37. Check the PENUMBRA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PENUMBRA INC worth?

PENUMBRA INC (PEN) has a market capitalization of 9.88B USD. This makes PEN a Mid Cap stock.


How many employees does PENUMBRA INC have?

PENUMBRA INC (PEN) currently has 4500 employees.


What are the support and resistance levels for PENUMBRA INC (PEN) stock?

PENUMBRA INC (PEN) has a support level at 242.7 and a resistance level at 254.47. Check the full technical report for a detailed analysis of PEN support and resistance levels.


Is PENUMBRA INC (PEN) expected to grow?

The Revenue of PENUMBRA INC (PEN) is expected to grow by 14.71% in the next year. Check the estimates tab for more information on the PEN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PENUMBRA INC (PEN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PENUMBRA INC (PEN) stock pay dividends?

PEN does not pay a dividend.


When does PENUMBRA INC (PEN) report earnings?

PENUMBRA INC (PEN) will report earnings on 2025-10-28, after the market close.


What is the Price/Earnings (PE) ratio of PENUMBRA INC (PEN)?

The PE ratio for PENUMBRA INC (PEN) is 72.19. This is based on the reported non-GAAP earnings per share of 3.51 and the current share price of 253.37 USD. Check the full fundamental report for a full analysis of the valuation metrics for PEN.


What is the Short Interest ratio of PENUMBRA INC (PEN) stock?

The outstanding short interest for PENUMBRA INC (PEN) is 4.77% of its float. Check the ownership tab for more information on the PEN short interest.


PEN Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to PEN. When comparing the yearly performance of all stocks, PEN is one of the better performing stocks in the market, outperforming 76.38% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PEN Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to PEN. PEN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PEN Financial Highlights

Over the last trailing twelve months PEN reported a non-GAAP Earnings per Share(EPS) of 3.51. The EPS increased by 41.53% compared to the year before.


Industry RankSector Rank
PM (TTM) 11.54%
ROA 8.82%
ROE 11.41%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%34.37%
Sales Q2Q%13.38%
EPS 1Y (TTM)41.53%
Revenue 1Y (TTM)12.92%

PEN Forecast & Estimates

23 analysts have analysed PEN and the average price target is 318.84 USD. This implies a price increase of 25.84% is expected in the next year compared to the current price of 253.37.

For the next year, analysts expect an EPS growth of 31.21% and a revenue growth 14.71% for PEN


Analysts
Analysts82.61
Price Target318.84 (25.84%)
EPS Next Y31.21%
Revenue Next Year14.71%

PEN Ownership

Ownership
Inst Owners91.21%
Ins Owners3.58%
Short Float %4.77%
Short Ratio3.75